NGS Group AB
STO:NGS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its Industry Average (15.2), the stock would be worth kr-5.77 (339% downside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -6.3 | kr2.41 |
0%
|
| Industry Average | 15.2 | kr-5.77 |
-339%
|
| Country Average | 15.9 | kr-6.03 |
-350%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| SE |
|
NGS Group AB
STO:NGS
|
59.8m SEK | -6.3 | -14.7 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
99.1B USD | 14 | 56 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.7B EUR | 10.7 | 13.5 | |
| US |
|
Cigna Corp
NYSE:CI
|
72.6B USD | 0 | 12.2 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 11.1 | 23.6 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
22.7B EUR | 12.3 | 17.9 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.8B USD | 14.4 | 21.4 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 15.9 | 24.7 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 6.5 | 11.1 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.6B USD | -65.6 | -27.9 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 10.4 | 13.9 |
Market Distribution
| Min | 0.3 |
| 30th Percentile | 10.7 |
| Median | 15.9 |
| 70th Percentile | 23.7 |
| Max | 9 494.9 |
Other Multiples
NGS Group AB
Glance View
NGS Group AB engages in the provision of executive search, recruitment, and placement services. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2002-03-25. The firm operates within three business sectors, namely School Replacement, Psychiatric and First Med. The School Replacement area offers temporary employment services to pre-schools, primary schools and secondary schools, and employs teachers, nannies, student assistants, cooks and kitchen assistants for both short and long term. The Psychiatric sector is engaged in the leasing of doctors and nurses to psychiatric clinics. The First Med sector is engaged in the leasing of nurses to municipalities and private health care operators, and employs specialists within such areas, as emergency care, geriatrics, primary care and healthcare administration. The firm operates through numerous subsidiaries, among others, Hemmafronten AB, Stjarnpoolen AB, Nurse Partner Scandinavia AB and Human Capital Group HCG AB.
